Early Access — free while we kick the tires
EdgarHawk

Ferguson Matthew

CHIEF FINANCIAL OFFICER

Officer
2 filings analyzed · 1 company · Latest 2025-12-18

Companies

Company Buys Sells Direction
ELUTIA INC. ELUT 3 0 Net buying

Activity

December 2025
2025-12-18 ELUTIA INC. ELUT
high
Buy
60,000 shares
$31,800
Significance 5/10

CFO Ferguson Matthew buys 60,000 shares of ELUT at $0.53; 4 other insiders buying within 14 days amid -88.8% decline from 52-week high.

Matthew acquired 60,000 shares at $0.53 on 2025-12-17, expanding his holdings by 15.5% to 447,110 shares, and now holds them at a current price of $0.54 against a 52-week high of $4.84. The company's most recent quarter reported revenue of $3,323,000 with net income of $-3,868,000, and annual revenue growth declined -1.5% year-over-year. Notably, 4 other insiders also purchased shares within the past 14 days, forming a cluster buy pattern during a period when the stock has fallen -88.8% from its 52-week peak and declined -50.5% over the past 90 days. Matthew's cross-ticker track record shows only 2 prior buys with timing outcomes not yet measurable, and his prior transactions at ELUT (December 1 and 2) likewise remain outcome-unresolved. This cluster activity occurred as the company operates unprofitably, creating an ambiguous signal: coordinated insider purchases at depressed valuations warrant attention, but the absence of positive near-term returns on Matthew's prior acquisitions and the company's deteriorating fundamentals limit clarity on insider conviction.

2025-12-03 ELUTIA INC. ELUT
low
Buy
10,000 shares
$6,610
Significance 3/10

CFO Matthew Ferguson bought 10,000 shares at $0.66 average (2 purchases) as ELUT stock down 86.6% from 52-week high.

Matthew Ferguson, Chief Financial Officer of Elutia Inc., executed 2 separate purchases totaling 10,000 shares (10.0K shares) for $6,610.00 over two consecutive days at prices of $0.65 and $0.67, increasing his holdings by 2.7% to 379,071 shares. This activity occurs in a context of significant stock deterioration: the current price of $0.65 represents an 86.6% decline from the 52-week high of $4.84, a 30-day decline of 30.5%, and a 90-day decline of 67.7%. The underlying business fundamentals remain challenged—the company posted a net loss of $3,868,000.00 in the latest quarter and has negative full-year profitability, with annual revenue contracting 1.5% year-over-year. Without scheduled transaction disclosure (10b5-1 plan flagging) or other context indicating this purchase was pre-planned, the filing itself provides no explicit basis for attributing strategic conviction to this acquisition at current depressed valuations. The transaction's modest scale relative to the insider's growing holdings and the company's deteriorating financial condition warrant observer attention to whether this represents confidence or liquidity management.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access